EP3179991
Meðferðarsamsetningar af BTK hindra og BCL-2 hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.8.2015EP published:
6.10.2021EP application number:
15757002.9
EP translation filed:
16.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
10.8.2035Expiry date:
10.8.2026Next due date:
31.8.2026
Title:
THERAPEUTIC COMBINATIONS OF A BTK INHIBITOR AND A BCL-2 INHIBITOR
Timeline
Today
11.8.2015EP application
6.10.2021EP Publication
16.11.2021Translation submitted
15.12.2021Registration published
10.8.2026Expires
Owner
Name:
Acerta Pharma B.V.Address:
Kloosterstraat 9, 5349 AB Oss, NL
Inventor
Name:
HAMDY, AhmedAddress:
Santa Cruz, CA 95060, US
Name:
ROTHBAUM, WayneAddress:
New York, NY 10023, US
Name:
IZUMI, RaquelAddress:
San Carlos, CA 94070, US
Name:
LANNUTTI, BrianAddress:
Solana Beach, CA 92075, US
Name:
COVEY, ToddAddress:
San Carlos, CA 94070, US
Name:
ULRICH, RogerAddress:
Sammamish, WA 98075, US
Name:
JOHNSON, DaveAddress:
Bainbridge Island, WA 98110-2548, US
Name:
BARF, TjeerdAddress:
5371 AS Ravenstein, NL
Name:
KAPTEIN, AllardAddress:
5301 HB Zaltbommel, NL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462035795 PDate:
11.8.2014Country:
US
Number:
201462088240 PDate:
5.12.2014Country:
US
Number:
201562115497 PDate:
12.2.2015Country:
US
Number:
201562181160 PDate:
17.6.2015Country:
US
Supplementary protection
SPC number:
SPC528
Classification
Categories:
A61K 31/437, A61K 31/4985, A61K 31/4155, A61K 31/416, A61K 31/00, A61K 31/454, A61K 31/519, A61K 39/395, A61K 45/06, A61K 31/675, A61K 31/4468
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 2.8.2022
Expires: 10.8.2023
Payer: Patice ehf.
Number: 9
Paid: 3.8.2023
Expires: 10.8.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.7.2024
Expires: 10.8.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.8.2025
Expires: 10.8.2026
Payer: Árnason Faktor ehf.